- Home
- NSA vs SYRE Comparison
NSA vs SYRE Comparison
Compare NSA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | SYRE |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NSA | SYRE |
|---|---|---|
| Price | $27.76 | $33.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $33.22 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 1.1M | 925.8K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | ★ 8.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $741,511,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.27 | N/A |
| P/E Ratio | $45.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.49 | $10.91 |
| 52 Week High | $40.62 | $35.31 |
Technical Indicators
Market Signals| Indicator | NSA | SYRE |
|---|---|---|
| Relative Strength Index (RSI) | 34.02 | 62.10 |
| Support Level | $29.01 | $32.50 |
| Resistance Level | $30.10 | $34.84 |
| Average True Range (ATR) | 0.56 | 1.48 |
| MACD | -0.16 | -0.37 |
| Stochastic Oscillator | 10.78 | 25.90 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.